Scientech Research’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Other funds holding UTHR
Scientech Research's UTHR Position: Q1 2026 in Review
Scientech Research sold out of United Therapeutics (UTHR) in Q1 2026, closing a stake of 1,855 shares — an estimated $904K sold.
Scientech Research first reported a position in UTHR in Q4 2023 and held it in 8 quarters. The position peaked at $1.77M in Q2 2025. 860 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.
- Scientech Research reported no remaining United Therapeutics position as of Q1 2026 after selling out during the quarter.
- Scientech Research sold 1,855 United Therapeutics shares in Q1 2026, an estimated $904K.
- Scientech Research first reported a position in United Therapeutics in Q4 2023 and held it in 8 quarters.
- Scientech Research's United Therapeutics position peaked at $1.77M in Q2 2025.
- 860 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.
Based on Scientech Research's 13F filing for Q1 2026, filed 15 May 2026.